Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2) [Phase 2]

View source ↗

Summary

Phase 2 trial update for stereotactic body radiation therapy in hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED